MATRIX

Norwegian Centre for Clinical Cancer Research with an overall ambition to extend the lives and improve quality of life of patients with hard-to-treat cancers.

[MATRIX @fkbmatrix]

@samhallsnytt Zero du da

[Kjetil Tasken @KjetilTasken]

Today we are writing in @Aftenposten about the new #protontherapy centers soon to open @Oslounivsykehus and @haukeland_no.

Read to find out why the cyclotron at the Radiumhospital is named «Ellen Gleditsch».

@DNVA1 #EirikMalinen #MarianneGuren @UniOslo

https://t.co/nBBLy5VCan

[MATRIX @fkbmatrix]

#HSØ har tradisjonen tro delt ut de beste førjulsgaver i form av tildelinger til nye forskningsprosjekter. Vi gratulerer @KjetilTasken og @AmundJon med to av disse tildelingene: https://t.co/lRN6LIDhbd

[MATRIX @fkbmatrix]

Stort engasjement på Symposium om offentlig tjenesteinnovasjon på @DNVA1 denne uken. Hva kjennetegner offentlig tjenesteinnovasjon? Hvordan sette i gang endringsprosesser? Takk til @KjetilTasken for en fantastisk dag👏

https://t.co/4vdzHkICBo

[MATRIX @fkbmatrix]

Vi er glade for å kunne kunngjøre at Novartis er første legemiddelselskap som offisielt er inne i vår nye forsker-initierte studie MATRIX-RARE👏 Les mer om studien og samarbeidet: https://t.co/8PAfyKJ1Oj
@HellandAslaug @KjetilTasken @Oslounivsykehus #TarjeBergdahl #Novartis

[MATRIX @fkbmatrix]

We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society
👏 We are excited that two projects connected to MATRIX are funded and congratulate @HellandAslaug, @KjetilTasken and their research teams: https://t.co/IN5XfxZ3G6

[Åslaug Helland @HellandAslaug]

The international lung cancer day, started with a focus from the TV-show "GodMorgenNorge".
Despite important improvements for subgroups of patients, lung cancer is still a disease with a poor prognosis, and more research is needed. @Lungekreft

[Oslounivsykehus @Oslounivsykehus]

#Johnson&Johnson joins #IMPRESS-Norway
@HellandAslaug @KjetilTasken @HRussnes @OusResearch @SveaassAnne @PRIMEROSE_EU @PCM4EU
https://t.co/TJMyUMOiZF

[MATRIX @fkbmatrix]

Lær mer om pasientsentrert behandling innen kreftbehandling og satsningen MyPath: https://t.co/5xtQu1kME7

@KaasaStein @LundebyTonje

[MATRIX @fkbmatrix]

We congratulate @SigridSkanland and the CLL-OUTCOME consortium on receiving funding from #EP PerMed👏: https://t.co/VTUvFkqra7

@OusResearch @Oslo universitetssykehus @KjetilTasken @HellandAslaug @HRussnes

[HealthTalk @HealthTalkNorge]

Nytt håp for #Brystkreftpasienter med hjernemetastaser! Studieresultater viser at Enhertu gir sterk effekt hos HER2-positive pasienter. Med godkjenning fra Beslutningsforum kan behandlingen tas i bruk umiddelbart. #Onkologi #Kreftforskning #ESMO2024
https://t.co/vMVxwxNx1d

[MATRIX @fkbmatrix]

Thank’s to all the organizers for two fantastic days at the Norwegian Cancer Symposium, marking the 70th aniversary of the ICR! Inspiring talks, good discussions, two vibrant poster sessions with almost 200 posters as well as delicious food👏👏👏

[MATRIX @fkbmatrix]

The Norwegian Cancer Symposium 2024 is marking the 70th anniversary of Institute for Cancer Research at @Oslounivsykehus.
Keynote speaker #DouglasHanahan kicked-off the scientific program with an excellent talk about Hallmarks of Cancer 2024.

[Kjetil Tasken @KjetilTasken]

Norwegian Cancer Symposium, Sept 9-10, 2024, celebrating 70 years of #CancerResearch at Institute for Cancer Research, @Oslounivsykehus, starts with >430 participants, speakers & invited guests. Look forward to talks by 15 invited speakers, 8 short talk speakers, and 118 posters.

[MATRIX @fkbmatrix]

Er du interessert i presisjonsmedisin og vil bli vår nye forskningskoordinator? Vi søker nå en prosjektkoordinator for to nasjonale kliniske studier: IMPRESS-Norway og MATRIX-RARE. Søknadsfrist 18. august: https://t.co/LgFZVuwTLl

[MATRIX @fkbmatrix]

The next Acta Oncologica Nordic Precision Cancer Medicine Symposium will take place in Oslo 15-17 September 2025 - save the date!
A special NPCM symposium collection originating from the NPCM2023 conference has now been published. For more information: https://t.co/pL0w51fnVC

[MATRIX @fkbmatrix]

Warm congratulations to @KjetilTasken on receiving the Excellent Researcher Award at @Oslounivsykehus 👏👏https://t.co/KUCabZ5NtK

[MATRIX @fkbmatrix]

@asmundflobak @eirini_tsi @NTNU @mtrkuiper Gratulerer til dere begge👏

[PCM4EU @PCM4EU]

PCM4EU’s white paper on molecular assays and molecular tumor boards for trial inclusion has been published in Journal of Internal Medicine👏 - many congratulations:
https://t.co/OI3qlmQtFX

[MATRIX @fkbmatrix]

@SigridSkanland planlegger et fotoprosjekt der hun portretterer ulike mennesker med en kreftdiagnose. Prosjektet har som mål å komme nærmere pasientene og vise at kreft kan ramme hvem som helst: https://t.co/V3DJzMfuPL